Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 3, 2007. The report serves as a notification of a change in major shareholding interests rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding shareholder ownership thresholds and contains no financial statement data.
Material Changes
The material change disclosed is a notification from Legal & General Group plc regarding its interest in GlaxoSmithKline plc ordinary shares. The notification indicates an acquisition or disposal of voting rights that resulted in the total position remaining below the 5% threshold.
- Notifying Entity: Legal & General Group plc (including subsidiaries LGIM, PMC, LGAS, and LGPL).
- Transaction Date: November 29, 2007.
- Notification Date: November 30, 2007.
- Threshold Status: Below 5% for the Group and LGIM.
- Specific Holdings Disclosed:
- Legal & General Group Plc (Direct): 255,111,994 shares (4.61%).
- Legal & General Investment Management (Holdings) Limited (Direct): 205,597,017 shares (3.72%).
- Total Voting Rights Base: 5,523,665,578.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, risk factors, contingencies, or unusual items. The document is strictly a compliance notification under DTR 5.8.12.
Investor Verification Checklist
- Verify the exact percentage of voting rights held by Legal & General Group plc and its subsidiaries as of November 29, 2007.
- Confirm whether the transaction involved an acquisition or disposal of shares.
- Check subsequent filings to determine if the Legal & General Group's stake crossed the 5% threshold in later periods.
- Review the company's annual report (Form 20-F) for the corresponding financial performance data, as it is absent in this filing.